Liquidia logo

Liquidia Share Price Today

(NASDAQ: LQDA)

Liquidia share price is $15.53 & ₹1,350.63 as on 6 Mar 2025, 2.30 'hrs' IST

$15.53

0.33

(2.2%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Liquidia share price in Dollar and Rupees. Guide to invest in Liquidia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Liquidia, along with analyst recommendations, forecasts, and comprehensive financials.

Liquidia share price movements

  • Today's Low: $15.08
    Today's High: $15.57

    Day's Volatility :3.15%

  • 52 Weeks Low: $8.26
    52 Weeks High: $16.99

    52 Weeks Volatility :51.38%

Liquidia (LQDA) Returns

PeriodLiquidia CorpSector (Health Care)Index (Russel 2000)
3 Months
35.28%
3.7%
0.0%
6 Months
71.6%
-2.8%
0.0%
1 Year
13.94%
2.5%
0.0%
3 Years
230.43%
12.9%
-11.6%

Liquidia (LQDA) Key Statistics

in dollars & INR

Previous Close
$15.195
Open
$15.2
Today's High
$15.57
Today's Low
$15.08
Market Capitalization
$1.3B
Today's Volume
$689.6K
52 Week High
$16.99
52 Week Low
$8.26
Revenue TTM
$15.6M
EBITDA
$-110.1M
Earnings Per Share (EPS)
$-1.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.73%

How to invest in Liquidia Stock (LQDA) from India?

It is very easy for Indian residents to invest directly in Liquidia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Liquidia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Liquidia or LQDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Liquidia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Liquidia shares which would translate to 0.056 fractional shares of Liquidia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Liquidia, in just a few clicks!

Returns in Liquidia (LQDA) for Indian investors in Rupees

The Liquidia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Liquidia investment value today

Current value as on today

₹1,18,889

Returns

₹18,889

(+18.89%)

Returns from Liquidia Stock

₹13,940 (+13.94%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Liquidia (LQDA)

-40%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Liquidia Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Liquidia

  • Caligan Partners LP

    9.59%

  • BlackRock Inc

    5.51%

  • Vanguard Group Inc

    4.20%

  • Farallon Capital Management, L.L.C.

    3.89%

  • Findell Capital Management LLC

    3.64%

  • Kynam Capital Management, LP

    2.68%

Analyst Recommendation on Liquidia

Buy

    84%Buy

    7%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Liquidia(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
1
1
1

Analyst Forecast on Liquidia Stock (LQDA)

What analysts predicted

Upside of 63.12%

Target:

$25.33

Current:

$15.53

Insights on Liquidia Stock (Ticker Symbol: LQDA)

  • Price Movement

    In the last 3 months, LQDA stock has moved up by 41.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.97M → 4.44M (in $), with an average increase of 18.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -40.92M → -23.15M (in $), with an average increase of 33.6% per quarter
  • LQDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 52.6%
  • Price to Sales

    ForLQDA every $1 of sales, investors are willing to pay $73.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

LQDA Liquidia Financials in INR & Dollars

FY18Y/Y Change
Revenue
$2.7M
↓ 62.7%
Net Income
$-53.1M
↑ 82.26%
Net Profit Margin
-2.0K%
↓ 1561.24%
FY19Y/Y Change
Revenue
$8.1M
↑ 198.2%
Net Income
$-46.4M
↓ 12.7%
Net Profit Margin
-574.69%
↑ 1388.23%
FY20Y/Y Change
Revenue
$739.6K
↓ 90.84%
Net Income
$-57.5M
↑ 23.93%
Net Profit Margin
-7.8K%
↓ 7198.3%
FY21Y/Y Change
Revenue
$12.9M
↑ 1637.81%
Net Income
$-29.8M
↓ 48.2%
Net Profit Margin
-231.7%
↑ 7541.29%
FY22Y/Y Change
Revenue
$15.9M
↑ 23.98%
Net Income
$-38.4M
↑ 28.82%
Net Profit Margin
-240.76%
↓ 9.06%
FY23Y/Y Change
Revenue
$17.5M
↑ 9.75%
Net Income
$-78.5M
↑ 104.62%
Net Profit Margin
-448.89%
↓ 208.13%
Q2 FY23Q/Q Change
Revenue
$4.8M
↑ 6.52%
Net Income
$-23.5M
↑ 79.05%
Net Profit Margin
-491.37%
↓ 199.05%
Q3 FY23Q/Q Change
Revenue
$3.7M
↓ 23.15%
Net Income
$-15.8M
↓ 32.86%
Net Profit Margin
-429.31%
↑ 62.06%
Q4 FY23Q/Q Change
Revenue
$4.5M
↑ 23.19%
Net Income
$-27.5M
↑ 73.84%
Net Profit Margin
-605.83%
↓ 176.52%
Q1 FY24Q/Q Change
Revenue
$3.0M
↓ 34.41%
Net Income
$-40.9M
↑ 49.1%
Net Profit Margin
-1.4K%
↓ 771.29%
Q2 FY24Q/Q Change
Revenue
$3.7M
↑ 23.12%
Net Income
$-27.9M
↓ 31.73%
Net Profit Margin
-763.65%
↑ 613.47%
Q3 FY24Q/Q Change
Revenue
$4.4M
↑ 21.56%
Net Income
$-23.2M
↓ 17.13%
Net Profit Margin
-520.57%
↑ 243.08%
FY18Y/Y Change
Profit
$2.6M
↓ 62.73%
FY19Y/Y Change
Profit
$7.3M
↑ 180.98%
FY20Y/Y Change
Profit
$501.9K
↓ 93.09%
FY21Y/Y Change
Profit
$9.8M
↑ 1858.58%
FY22Y/Y Change
Profit
$13.1M
↑ 33.02%
FY23Y/Y Change
Profit
$14.6M
↑ 11.65%
Q2 FY23Q/Q Change
Profit
$4.1M
↑ 7.19%
Q3 FY23Q/Q Change
Profit
$3.1M
↓ 24.47%
Q4 FY23Q/Q Change
Profit
$3.3M
↑ 4.89%
Q1 FY24Q/Q Change
Profit
$1.2M
↓ 62.7%
Q2 FY24Q/Q Change
Profit
$2.2M
↑ 78.13%
Q3 FY24Q/Q Change
Profit
$2.9M
↑ 33.1%
FY18Y/Y Change
Operating Cash Flow
$-31.8M
↑ 31.04%
Investing Cash Flow
$-870.9K
↓ 65.77%
Financing Cash Flow
$68.8M
↑ 138.83%
FY19Y/Y Change
Operating Cash Flow
$-48.3M
↑ 51.69%
Investing Cash Flow
$-1.9M
↑ 112.42%
Financing Cash Flow
$66.4M
↓ 3.52%
FY20Y/Y Change
Operating Cash Flow
$-54.1M
↑ 12.14%
Investing Cash Flow
$247.9K
↓ 113.4%
Financing Cash Flow
$63.4M
↓ 4.48%
FY21Y/Y Change
Operating Cash Flow
$-34.0M
↓ 37.14%
Investing Cash Flow
$-107.2K
↓ 143.25%
Financing Cash Flow
$26.3M
↓ 58.5%
FY22Y/Y Change
Operating Cash Flow
$-28.6M
↓ 16.01%
Investing Cash Flow
$-587.0K
↑ 447.47%
Financing Cash Flow
$65.0M
↑ 146.82%
Q2 FY23Q/Q Change
Operating Cash Flow
$-5.6M
↓ 34.21%
Investing Cash Flow
$-243.0K
↑ 0.0%
Financing Cash Flow
$-409.0K
↓ 104.11%

Liquidia Technicals Summary

Sell

Neutral

Buy

Liquidia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Liquidia (LQDA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Liquidia Corp logo
2.51%
71.6%
13.94%
230.43%
230.43%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Liquidia Corp logo
NA
NA
NA
0.0
-1.51
-0.38
NA
1.31
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Liquidia Corp logo
Buy
$1.3B
230.43%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Organization
Liquidia
Employees
145
CEO
Dr. Roger A. Jeffs Ph.D.
Industry
Health Technology

Management People of Liquidia

NameTitle
Dr. Roger A. Jeffs Ph.D.
CEO & Director
Mr. Michael Kaseta
COO & CFO
Mr. Russell Schundler
General Counsel & Corporate Secretary
Mr. William R. Kenan Jr.
Co-Founder
Dr. Ginger Denison
Co-Founder
Ms. Sarah Krepp SPHR
Senior Vice President of People & Culture
Mr. Jason Adair
Chief Business Officer
Mr. Scott Moomaw
Chief Commercial Officer
Dr. Rajeev Saggar M.D.
Chief Medical Officer
Mr. Michael Hunter
Senior Vice President of Manufacturing Operations

Important FAQs about investing in LQDA Stock from India :

What is Liquidia share price today?

Liquidia share price today stands at $15.53, Open: $15.20 ; Previous Close: $15.20 ; High: $15.57 ; Low: $15.08 ; 52 Week High: $16.99 ; 52 Week Low: $8.26.

The stock opens at $15.20, after a previous close of $15.20. The stock reached a daily high of $15.57 and a low of $15.08, with a 52-week high of $16.99 and a 52-week low of $8.26.

Can Indians buy Liquidia shares?

Yes, Indians can invest in the Liquidia (LQDA) from India.

With INDmoney, you can buy Liquidia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Liquidia at zero transaction cost.

How can I buy Liquidia shares from India?

It is very easy to buy Liquidia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Liquidia (LQDA) be purchased?

Yes, you can buy fractional shares of Liquidia with INDmoney app.

What are the documents required to start investing in Liquidia stocks?

To start investing in Liquidia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Liquidia Stock (LQDA)?

Today’s highest price of Liquidia (LQDA) is $15.57.

Today’s lowest price of Liquidia (LQDA) is $15.08.

What is today's market capitalisation of Liquidia?

Today's market capitalisation of Liquidia LQDA is 1.3B

What is the 52 Week High and Low Range of Liquidia Stock (LQDA)?

  • 52 Week High

    $16.99

  • 52 Week Low

    $8.26

What are the historical returns of Liquidia (LQDA)?

  • 1 Month Returns

    2.51%

  • 3 Months Returns

    71.6%

  • 1 Year Returns

    13.94%

  • 5 Years Returns

    230.43%

Who is the Chief Executive Officer (CEO) of Liquidia ?

Dr. Roger A. Jeffs Ph.D. is the current Chief Executive Officer (CEO) of Liquidia.